Compare Compass Inc. Class A Common Stock (COMP) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Compass Inc. Class A Common Stock vs Edwards Lifesciences Corporation Common Stock — how do they compare? Compass Inc. Class A Common Stock trades at $9.38 (market cap $7.31B), while Edwards Lifesciences Corporation Common Stock trades at $85.25 (market cap $48.56B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 6.6× Compass Inc. Class A Common Stock's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Compass Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals.
| COMP | EW | |
|---|---|---|
Market Cap | $7.31B | $48.56B |
Volume | 15,861,865 | 6,520,488 |
Sector | Real Estate | Health |
52-Week High | $13.58 | $95.18 |
52-Week Low | $6.68 | $72.65 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $10.72B | $45.01B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Compass Inc. Class A Common Stock
Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.
Read more on COMP →About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →
